Daiwa Securities Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Daiwa Securities Group's BEAM Position: Q1 2026 in Review
Daiwa Securities Group sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 302 shares — an estimated $8K sold.
Daiwa Securities Group first reported a position in BEAM in Q4 2020 and held it in 21 quarters. The position peaked at $84K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Daiwa Securities Group reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 302 Beam Therapeutics shares in Q1 2026, an estimated $8K.
- Daiwa Securities Group first reported a position in Beam Therapeutics in Q4 2020 and held it in 21 quarters.
- Daiwa Securities Group's Beam Therapeutics position peaked at $84K in Q3 2025.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.